Tenderwize
Wróć do wyszukiwania

Pharmaceutical discount agreements with joining option

BARMER Beschaffung und Vergabe·Wuppertal, Germany·Deadline May 01, 2027 · 247 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisać
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Arzneimittelrabattverträge mit Beitrittsoption

40/100

Ocena szansy

Needs reviewLow complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

40 / 100

Złożoność

20 / 100

Czynniki ryzyka

Critical information such as estimated value, award criteria, and eligibility requirements are not provided in the noti...

The notice disclaims applicability of EU procurement directives, which may reduce legal recourse in case of disputes.

No procurement documents available

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Sep 2027
  • Supply of pharmaceutical products containing the active ingredient Lercanidipin.
  • Framework agreement with a joining option (Beitrittsoption), allowing other entities to join.
Pokaż pełne podsumowanie

This is a voluntary transparency notice for a framework agreement with a joining option for pharmaceutical products, specifically the active ingredient Lercanidipin, issued by BARMER. The framework runs from 1 May 2025 to 30 September 2027, with a possible extension of 3 months. The notice explicitly states it is not a public procurement under EU Directive 2014/24/EU. Submission deadline is 1 May 2027 at 10:35 CEST. No estimated value or award criteria are provided.

Ryzyka

Critical information such as estimated value, award criteria, and eligibility requirements are not provided in the noti...

The notice disclaims applicability of EU procurement directives, which may reduce legal recourse in case of disputes.

No procurement documents available

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • The notice is not a public procurement under EU Directive 2014/24/EU; it is a voluntary transparency notice.
  • Multiple tenders are allowed (up to 999).
  • Variants are not allowed.

Zamawiający

Lokalizacja

Wuppertal, DEU

Identyfikator

992-80322-57

Działalność

Health

Części (1)

LOT-0000

Pharmaceutical discount agreements with joining option

Framework agreement for the supply of pharmaceutical products containing the active ingredient Lercanidipin. The framework includes a one-time extension option of 3 months until 30 September 2027. Details are available in the procurement documents.

SuppliesFrameworkEU fundedElectronic submission

Czas trwania

Apr 2025 - Sep 2027

Kategoria

Pharmaceutical products

Termin

Deadline May 01, 2027

Szczegóły zamówienia

Data publikacji
26 Mar 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
197516-2025

Dokumenty (1)

Portal składania ofert 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3